Biostage, Inc. (BSTG) 是一家上市公司 属于 医疗保健 板块，经营于 生物科技 行业. 公司总部位于 Holliston, MA, 美国. 现任CEO为 Junli He.
BSTG 拥有 IPO日期为 2013-10-21, 7 名全职员工, 在 Other OTC, 市值为 $57.82M.
Biostage, Inc., a biotechnology company, offers products to cure patients of cancers, injuries, and birth defects of the gastro-intestinal tract and the airways. The company is engaged in developing Biostage Esophageal Implant for the treating esophageal cancer. The company was formerly known as Harvard Apparatus Regenerative Technology, Inc. and changed its name to Biostage, Inc. in March 2016. Biostage, Inc. was founded in 2009 and is headquartered in Holliston, Massachusetts.
